Mostly Cloudy 46°
Tag:

Phase 3 Clinical Trial

News
COVID-19: New US-Made Vaccine Has 90 Percent Efficiency Rate, Can Be Stored In Refrigerators COVID-19: New US-Made Vaccine Has 90 Percent Efficiency Rate, Can Be Stored In Refrigerators
Covid-19: New Us-made Vaccine Has 90 Percent Efficiency Rate, Can Be Stored In Refrigerators An American biotech company announced that it has concluded the latest phase of clinical trials for its COVID-19 vaccine, which has proven to be highly effective. Novavax announced on Monday, June 14 that its vaccine has an overall efficacy rate of 90.4 percent in a Phase 3 trial that took place across the United States and Mexico. The Novavax vaccine can be stored in standard refrigerators, making it easier to distribute. Additional analysis of the trial is ongoing, according to the company, and will be submitted to peer-reviewed journals for publication. 
The company said that the vacc…

SHARE

by Zak Failla